Flomenberg Neal 4
4 · Tevogen Bio Holdings Inc. · Filed Mar 14, 2025
Insider Transaction Report
Form 4
Flomenberg Neal
See Remarks
Transactions
- Sale
Common Stock
2025-03-12$1.09/sh−232,968$253,935→ 3,595,608 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were made solely to satisfy the payment of tax obligations relating to the vesting and subsequent settlement of restricted stock units. Such sales were not made at the discretion of the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.05 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.